X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MYLAN
Dec-14
ALKEM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,5894,292-   
Low Rs1,2323,025-   
Sales per share (Unadj.) Rs417.51,469.4-  
Earnings per share (Unadj.) Rs56.3177.0-  
Cash flow per share (Unadj.) Rs64.7284.9-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9730.5-  
Shares outstanding (eoy) m119.57378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.42.5 135.7%   
Avg P/E ratio x25.120.7 121.2%  
P/CF ratio (eoy) x21.812.8 169.8%  
Price / Book Value ratio x4.85.0 96.1%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,384,310 12.2%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM22,239.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,679.1-  
INCOME DATA
Net Sales Rs m49,915555,994 9.0%  
Other income Rs m1,645-3,241 -50.8%   
Total revenues Rs m51,561552,754 9.3%   
Gross profit Rs m8,482138,278 6.1%  
Depreciation Rs m1,00640,835 2.5%   
Interest Rs m67123,983 2.8%   
Profit before tax Rs m8,45170,220 12.0%   
Minority Interest Rs m-114-288 39.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,953 54.4%   
Profit after tax Rs m6,73166,979 10.0%  
Gross profit margin %17.024.9 68.3%  
Effective tax rate %19.04.2 451.9%   
Net profit margin %13.512.0 111.9%  
BALANCE SHEET DATA
Current assets Rs m27,062488,793 5.5%   
Current liabilities Rs m15,324382,138 4.0%   
Net working cap to sales %23.519.2 122.6%  
Current ratio x1.81.3 138.1%  
Inventory Days Days6778 85.2%  
Debtors Days Days41107 38.5%  
Net fixed assets Rs m12,610128,628 9.8%   
Share capital Rs m23919,661 1.2%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,027276,384 12.7%   
Long term debt Rs m1,212412,891 0.3%   
Total assets Rs m54,3871,113,249 4.9%  
Interest coverage x13.63.9 346.3%   
Debt to equity ratio x01.5 2.3%  
Sales to assets ratio x0.90.5 183.8%   
Return on assets %13.68.2 166.6%  
Return on equity %19.224.2 79.3%  
Return on capital %24.913.6 182.4%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,25973,086 9.9%  
From Investments Rs m1,864-57,638 -3.2%  
From Financial Activity Rs m-9,273-19,258 48.1%  
Net Cashflow Rs m-150-3,810 3.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 72.02 Rs / USD

Compare ALKEM LABORATORIES With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: DIVIS LABORATORIES  ALEMBIC LTD  TTK HEALTHCARE  CIPLA  GSK PHARMA  



Today's Market

Sensex Trades Over 250 Points Up; Tata Motors & Power Grid Top Gainers(12:30 pm)

Stock markets in India are presently trading higher. The BSE Sensex is trading higher by 252 points and the NSE Nifty is trading higher by 59 points.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Dec 17, 2018 03:35 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS